Cytochemistry and Flow Cytometry in Leukemia

Cytochemistry and flow cytometry are the laboratory techniques that turn a leukemia diagnosis from a morphologic impression into a defined lineage and immunophenotype. Cytochemical stains reveal enzymatic and metabolic properties of leukemic cells, while multiparameter flow cytometry measures many surface and intracellular markers simultaneously, together assigning lineage and detecting measurable residual disease.

Definition

Cytochemistry and flow cytometry are laboratory methods for characterizing leukemic cells: cytochemistry uses stains that reveal enzymatic or biochemical features (for example myeloperoxidase activity), and multiparameter flow cytometry measures multiple surface and intracellular antigens per cell to assign lineage, define immunophenotype, and quantify residual disease.

Scope

This topic covers the methods used to characterize leukemic cells beyond morphology: classic cytochemical stains such as myeloperoxidase, and modern multiparameter flow cytometric immunophenotyping, including standardized antibody panels and the detection of measurable (minimal) residual disease. It is reference material on laboratory methodology, not a clinical protocol.

Key concepts

• Myeloperoxidase and other cytochemical stains
• Lineage assignment by immunophenotype
• Multiparameter (multicolor) flow cytometry
• Standardized antibody panels
• Aberrant antigen expression
• Gating and population analysis
• Measurable (minimal) residual disease detection

Mechanisms

Cytochemical stains exploit cell-specific enzymes and constituents: myeloperoxidase activity, for example, marks the myeloid lineage and helps separate acute myeloid from acute lymphoblastic leukemia on a stained smear. Flow cytometry suspends cells in a stream past lasers and records light scatter and fluorescence from antibody-bound markers, allowing many antigens to be measured on each cell; characteristic and aberrant antigen combinations define lineage and identify the leukemic population. The same approach, applied at high sensitivity with standardized panels, detects small residual leukemic populations after treatment as measurable residual disease (van Dongen et al., 2012; Schuurhuis et al., 2018).

Clinical relevance

These techniques underpin the lineage assignment and immunophenotyping that modern leukemia classification depends on, and flow cytometric measurable-residual-disease assessment has become an important response marker in the literature. This entry describes the methods at a reference level and is not guidance for interpreting an individual patient's results.

Evidence & guidelines

Standardization efforts such as the EuroFlow antibody panels define reproducible flow cytometric immunophenotyping, and the European LeukemiaNet MRD Working Party provides consensus criteria for measurable residual disease assessment in acute myeloid leukemia; lineage criteria are also embedded in the WHO classification (van Dongen et al., 2012; Schuurhuis et al., 2018; Arber et al., 2016).

History

Cytochemical staining was the original means of refining the morphologic diagnosis of acute leukemia and assigning lineage. Flow cytometric immunophenotyping then largely supplanted cytochemistry for lineage assignment by measuring many antigens per cell, and standardization initiatives and measurable-residual-disease consensus documents later extended its role into reproducible, high-sensitivity assessment (van Dongen et al., 2012; Schuurhuis et al., 2018).

Seminal works

• van-dongen-2012
• schuurhuis-2018

Frequently asked questions

Why is myeloperoxidase staining useful in acute leukemia?

Myeloperoxidase is a marker of the myeloid lineage, so its presence on a cytochemical stain supports a diagnosis of acute myeloid leukemia and helps distinguish it from acute lymphoblastic leukemia.

What is measurable residual disease detection by flow cytometry?

It is the use of high-sensitivity multiparameter flow cytometry to detect small populations of leukemic cells that persist after treatment, below the level visible on routine morphology, as a marker of response.